Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huib A Kerstjens

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Respiratory Medicine|May 15, 2010
Tolerability and efficacy of inhaled AZD4818, a CCR1 antagonist, in moderate to severe COPD patientsHuib A Kerstjens, Leif Bjermer, Leif Eriksson, et al.
Contemporary Clinical Trials Communications|December 10, 2024
Run-in periods and treatment outcomes in asthma trials: A narrative reviewEmilio Pizzichini, Guy Brusselle, Dawn Edwards, et al.
American Journal of Industrial Medicine|October 1, 2011
Acute respiratory effects in firefightersFrans E Greven, Esmeralda J Krop, Jack J Spithoven, et al.
Respiratory Research|July 10, 2007
Reduced inflammatory response in cigarette smoke exposed Mrp1/Mdr1a/1b deficient miceMargaretha van der Deen, Wim Timens, Hetty Timmer-Bosscha, et al.
Respiratory Medicine|September 27, 2017
Blood eosinophilia as a marker of early and late treatment failure in severe acute exacerbations of COPDHendrik J Prins, Ruud Duijkers, Rene Lutter, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 22, 2024
Characterization of Moderate and Severe Asthma Exacerbations in the CAPTAIN StudyJohn Oppenheimer, Huib A Kerstjens, Louis-Philippe Boulet, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Respiratory Medicine|May 15, 2010
Tolerability and efficacy of inhaled AZD4818, a CCR1 antagonist, in moderate to severe COPD patientsHuib A Kerstjens, Leif Bjermer, Leif Eriksson, et al.
Contemporary Clinical Trials Communications|December 10, 2024
Run-in periods and treatment outcomes in asthma trials: A narrative reviewEmilio Pizzichini, Guy Brusselle, Dawn Edwards, et al.
American Journal of Industrial Medicine|October 1, 2011
Acute respiratory effects in firefightersFrans E Greven, Esmeralda J Krop, Jack J Spithoven, et al.
Respiratory Research|July 10, 2007
Reduced inflammatory response in cigarette smoke exposed Mrp1/Mdr1a/1b deficient miceMargaretha van der Deen, Wim Timens, Hetty Timmer-Bosscha, et al.
Respiratory Medicine|September 27, 2017
Blood eosinophilia as a marker of early and late treatment failure in severe acute exacerbations of COPDHendrik J Prins, Ruud Duijkers, Rene Lutter, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 22, 2024
Characterization of Moderate and Severe Asthma Exacerbations in the CAPTAIN StudyJohn Oppenheimer, Huib A Kerstjens, Louis-Philippe Boulet, et al.
Pageof 1